Clinical Trial Update: 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating 13C-Methacetin Breath Test to predict outcomes in acute liver failure; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Acute Liver Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-12-22